This inventor holds 1 USPTO granted patent. Top assignee: Peloton Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Keshi Wang in CD73 Modulation
Introduction
Keshi Wang is an accomplished inventor based in Foster City, CA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of CD73 activity. Her work focuses on developing compounds that can effectively inhibit CD73, which is crucial for treating various diseases associated with its activity.
Latest Patents
Keshi Wang holds a patent for "Compositions and methods for inhibiting CD73." This patent describes compounds that modulate CD73 activity, pharmaceutical compositions containing these compounds, and methods for using these compounds to treat diseases linked to CD73 activity. This innovation represents a promising advancement in therapeutic options for patients.
Career Highlights
Keshi Wang is currently employed at Peloton Therapeutics, Inc., where she continues to explore innovative solutions in drug development. Her expertise and dedication to her research have positioned her as a key figure in her field.
Collaborations
Throughout her career, Keshi has collaborated with notable colleagues, including Bin Wang and Hanbiao Yang. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Keshi Wang's contributions to the field of CD73 modulation exemplify her commitment to advancing medical science. Her innovative work at Peloton Therapeutics, Inc. continues to pave the way for new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile